When a publicly traded company faces delisting from a major exchange like the NYSE or NASDAQ, the transition to the OTC (Over-the-Counter) Markets can feel like a downgrade—but it doesn’t have to be a death sentence. In fact, how your leadership team manages investor relations during this transitional period can determine the long-term success or failure of your company’s public market presence.
At Cervitude LLC, we specialize in investor relations services that help companies not just survive—but thrive—during delisting transitions. Here’s how to handle investor relations (IR) strategically when your company is moving from a national exchange to the OTC.
1. Control the Narrative with Transparent Communication
Don’t let speculation fill the silence. The moment delisting becomes a possibility—or a certainty—you must proactively communicate with your shareholders. Create a formal press release, publish FAQs on your IR website, and offer a direct channel for investor questions.
Key messages should include:
- Why the company is delisting
- What this means operationally and strategically
- Your plan to remain transparent and engaged
- Potential relisting strategy (if applicable)
💡 Cervitude Tip: Publish a short, clear video message from the CEO. Humanizing your leadership during transitions builds trust.
2. Revamp Your IR Website for the OTC Audience
OTC investors are a unique group. They often value deep due diligence, operational insights, and undervalued growth stories. Once you move to OTC, your investor-facing assets need to be updated.
Must-have IR assets:
- Updated company overview and strategy deck
- Clear access to financials (even if unaudited)
- Transfer agent and contact information
- Press release archive and corporate updates
💡 SEO Tip: Optimize your IR website and press content with keywords like “OTC stock,” “delisted stock strategy,” and your ticker symbol.
3. Increase Frequency of Investor Updates
You’re no longer bound by the strict filing timelines of the major exchanges—but this is not an excuse to go dark.
Increase the cadence of updates:
- Monthly newsletters or video updates
- Bi-weekly social media insights (especially on LinkedIn and X)
- Quarterly summaries even if not formally required
💡 Cervitude Can Help: We craft and distribute IR newsletters, CEO letters, and investor video updates tailored for OTC investors.
4. Address the Stigma Head-On
Many investors see a move to OTC as a red flag. To manage this, frame the transition as strategic rather than reactive.
Sample messaging:
- “We are temporarily repositioning on the OTC Markets while optimizing operations and profitability.”
- “Our goal is to maintain liquidity and transparency while preparing for future uplisting.”
Be honest, but also highlight strengths and forward momentum.
5. Utilize Third-Party Platforms & Outreach
OTC investors look to sources like OTCMarkets.com, InvestorHub, and StockTwits for information. Actively participate or monitor these platforms to shape the narrative and identify misconceptions early.
Additionally:
- Attend microcap conferences (online and offline)
- Work with IR firms (like Cervitude) to introduce your story to new retail and institutional investors
💡 Bonus: Get analyst coverage or interviews on microcap YouTube channels and podcasts to expand visibility.
6. Be Ready to Rebuild Trust
Delisting often bruises investor confidence. The only path forward is consistent performance and open communication.
- Deliver on promises (no hype)
- Share timelines and hit them
- Treat every shareholder like a partner, regardless of share count
Over time, performance and communication will turn skeptics into supporters.
Final Thoughts
Delisting from a major exchange is a setback—but it’s not the end. With a robust investor relations strategy, clear communication, and proactive outreach, your company can successfully manage the transition to the OTC Markets and position itself for long-term recovery or relisting.
At Cervitude LLC, we’ve helped public companies at every stage—from IPOs to relistings—craft and execute powerful investor relations campaigns. If you’re facing delisting or have already moved to the OTC, contact us to build a customized IR recovery plan.
📞 Let’s Talk: www.Cervitude.com/contact
📈 Explore Our Services: Investor Relations Solutions